Thomas Hallam's most recent trade in Palisade Bio Inc was a trade of 40,000 Common Stock, par value $0.01 done at an average price of $0.3 . Disclosure was reported to the exchange on Aug. 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Aug 2022 | 40,000 | 57,592 | - | 0.3 | 10,000 | Common Stock, par value $0.01 |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2022 | 40,000 | 40,000 | - | - | Series 2 Common Stock Purchase Warrant | |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 16 Aug 2022 | 40,000 | 40,000 | - | - | Series 1 Common Stock Purchase Warrant | |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 28 Mar 2022 | 10,000 | 17,592 | - | 1.2 | 11,800 | Common Stock |
| Palisade Bio Inc | Thomas M. Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 156,600 | 156,600 | - | - | Stock Option (right to buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.49 per share. | 21 Sep 2021 | 6,000 | 7,592 | - | 2.5 | 14,940 | Common Stock |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 95,572 | 95,572 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 27,190 | 27,190 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 27,189 | 27,189 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 22,730 | 22,730 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 20,392 | 20,392 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 15,002 | 15,002 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 12,294 | 12,294 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 8,754 | 8,754 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,797 | 6,797 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 4,078 | 4,078 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 2,719 | 2,719 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 1,592 | 1,592 | - | - | Common Stock | |
| Palisade Bio Inc | Thomas Hallam | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 477 | 477 | - | - | Stock Option (Right to Buy) |